Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
CIPLA

CIPLA Recalls

All product recalls associated with CIPLA.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 21–25 of 25 recalls

Esomeprazole Magnesium Suspension 40mg (CIPLA) – Cross-Contamination (2020)

Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline

Class IIModerate

FDADec 17, 2020Nationwide• CIPLA

Esomeprazole Magnesium Suspension (CIPLA) – contamination risk (2020)

Cross- contamination with other products: The excipient, Crospovidone, NF is contaminated with theophylline

Class IIModerate

FDADec 17, 2020Nationwide• CIPLA

Azacitidine Injection (CIPLA) – sterility seal issue (2020)

cGMP deviations: Vials may not be sealed correctly affecting sterility.

Class IIModerate

FDADec 14, 2020Nationwide• CIPLA

Nevirapine Extended Release Tablets (Cipla) – failed dissolution (2018)

Failed Dissolution Specifications.

Class IIModerate

FDADec 14, 2018Nationwide• Cipla Limited

Levalbuterol Inhalation Solution (Cipla) – Impurity Specification Failure (2015)

Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.

Class IIILow

FDAApr 24, 2015Nationwide• Cipla Limited

Page 2 of 2Next